Acasti Pharma Inc.
ACST
Rangering i aksjer
#29738
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Aksjekurs
$0.41258382
Sist synkronisert: 2023-03-27
Markedsverdi
$18.41M
Endring (1 dag)
-0.09%
Endring (1 år)
-87.42%
Land
CA
Handel Acasti Pharma Inc. (ACST)
Kategori
Healthcare
Aksjeprishistorikk for Acasti Pharma Inc. (ACST)
Høyeste sluttskurs: $3.14 den 2024-11-01
Laveste sluttskurs: $726.00 den 2012-02-01
Laveste sluttskurs: $726.00 den 2012-02-01
Aksjeprishistorikk for Acasti Pharma Inc. fra 2012 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2024 | 34.72% |
| 2023 | -9.30% |
| 2022 | -64.98% |
| 2021 | -48.82% |
| 2020 | -86.25% |
| 2019 | 209.96% |
| 2018 | -47.13% |
| 2017 | 2.86% |
| 2016 | -43.73% |
| 2015 | -54.07% |
| 2014 | -59.53% |
| 2013 | -48.78% |
| 2012 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
